Publicaciones en las que colabora con Javier Pérez Gisbert (15)

2021

  1. Antibiotic resistance prevalence and trends in patients infected with helicobacter pylori in the period 2013–2020: Results of the european registry on h. pylori management (hp-eureg)

    Antibiotics, Vol. 10, Núm. 9

  2. European registry on helicobacter pylori management: Effectiveness of first and second-line treatment in Spain

    Antibiotics, Vol. 10, Núm. 1, pp. 1-15

  3. Follow-up study confirms the presence of gastric cancer dna methylation hallmarks in high-risk precursor lesions

    Cancers, Vol. 13, Núm. 11

2018

  1. Genetic variation analysis in a follow-up study of gastric cancer precursor lesions confirms the association of MUC2 variants with the evolution of the lesions and identifies a significant association with NFKB1 and CD14

    International Journal of Cancer, Vol. 143, Núm. 11, pp. 2777-2786

2017

  1. Correlation between adenoma detection rate in colonoscopy- and fecal immunochemical testing-based colorectal cancer screening programs

    United European Gastroenterology Journal, Vol. 5, Núm. 2, pp. 255-260

2014

  1. Rate of Detection of Advanced Neoplasms in Proximal Colon by Simulated Sigmoidoscopy vs Fecal Immunochemical Tests

    Clinical Gastroenterology and Hepatology, Vol. 12, Núm. 10, pp. 1708-1716.e4

2011

  1. Clinical patterns and outcomes of ischaemic colitis: Results of the Working Group for the Study of Ischaemic Colitis in Spain (CIE study)

    Scandinavian Journal of Gastroenterology, Vol. 46, Núm. 2, pp. 236-246

2010

  1. Helicobacter pylori first-line treatment and rescue option containing levofloxacin in patients allergic to penicillin

    Digestive and Liver Disease, Vol. 42, Núm. 4, pp. 287-290

2008

  1. Eradication of Helicobacter pylori for the prevention of peptic ulcer rebleeding

    Alimentary Pharmacology and Therapeutics

  2. Recurrence of Helicobacter pylori infection: 3650 patient-years follow-up study

    Helicobacter

  3. Second-line rescue therapy with levofloxacin after H. pylori treatment failure: A Spanish multicenter study of 300 patients

    American Journal of Gastroenterology, Vol. 103, Núm. 1, pp. 71-76

2007

  1. Eradication of Helicobacter pylori for the prevention of peptic ulcer rebleeding

    Helicobacter, Vol. 12, Núm. 4, pp. 279-286

2006

  1. Recurrence of Helicobacter pylori infection after several eradication therapies: Long-term follow-up of 1000 patients

    Alimentary Pharmacology and Therapeutics, Vol. 23, Núm. 6, pp. 713-719

  2. Third-line rescue therapy with levofloxacin after two H. pylori treatment failures

    American Journal of Gastroenterology, Vol. 101, Núm. 2, pp. 243-247

2004

  1. The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti-inflammatory drug use is negligible in Southern Europe

    Helicobacter, Vol. 9, Núm. 3, pp. 249-254